Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Aspira Women's Health Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 24 | 23 | −1 |
| Shares | 715.3K | 1.89M | +1.18M (+164.6%) |
| Value | $2.92M | $6.15M | +$3.23M (+110.8%) |
New holders (2)
Institutions that held Aspira Women's Health Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 1,157,000 | $3.59M | 0.10% |
| Fernwood Investment Management, LLC | 666 | $2.06K | 0.00% |
Sold out (3)
Institutions that held Aspira Women's Health Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| HRT Financial LP | 11,262 | $45.0K |
| Northwestern Mutual Wealth Management Co | 493 | $2.01K |
| FMR LLC | 26 | $106 |